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Abstract. The cyanoamidation of olefins was achieved. When N-(2-vinylphenyl)cyanoformamides were 
treated with palladium catalyst, intramolecular cyanoamidation took place to give corresponding 
3,3-disubstituted oxindoles. P(t-Bu)3 showed a remarkable effect on this reaction. When it was used with 
Pd(dba)2, the reaction was completed in 15 min at 100 oC for many substrates. Furthermore, the 
enantioselective cyanoamidation was accomplished with Pd(dba)2 and an optically active 
phosphoramidite to provide optically active 3,3-disubstituted oxindoles. Manipulation of the resulting 




Compounds possessing the 3,3-disubstituted oxindole substructure have received considerable 
pharmacological attention, and have frequently been used as synthetic intermediates for indole alkaloid 
synthesis.1 To obtain optically active 3,3-disubstituted oxindoles, various classes of enantioselective 
methodologies have been applied. These can be classified on the basis of retrosynthetic disconnection 
(Figure 1). Formation of the bond between C(3) and the benzene ring (path a), represents an 
enantioselective Heck reaction pioneered by Overman et al.2 Recently, this strategy has been expanded to 
an arylpalladation−cyanation cascade.3 Alternatively, the same bond was constructed through 
palladium-catalyzed enantioselective intramolecular α-arylation of acetanilide derivatives.4 The strategies 
starting from 3-monosubstituted oxindole (path b) have also been extensively studied; namely, optically 
active pyridine-catalyzed acyl migrations,5 palladium- or molybdenum-catalyzed allylations,6 
palladium-catalyzed trimethylenemethane [3+2]-cycloadditions,7 cinchona-alkaloid-catalyzed 
enantioselective aldol-type reactions,8 palladium-catalyzed enantioselective arylations and vinylations,9 
organocatalytic Mannich reactions,10 and enantioselective Claisen rearrangements.11,12 In this project, we 
studied the synthesis of optically active 3,3-disubstituted oxindoles by bond formation between an amide 





































Figure 1. Enantioselective synthesis of 3,3-disubstituted oxindoles. 
 
Recently, we have been interested in developing lactam formation through intramolecular insertion of 
carbamoyl transition metal complexes (Figure 2).13 The catalytic process starts with the oxidative addition 
of formamide derivatives to low valent transition metal species to generate carbamoyl complex A. This 
complex undergoes ring closure via amidometalation. Either reductive elimination or β-hydride 
elimination leads to the final product. The advantages of our strategy are: i) providing access to highly 
functionalized and substituted lactams, ii) in a single step, iii) from readily available starting materials, 

































Figure 2. Synthesis of lactams through carbamoyl transition metal complexes. 
 
In line with this reaction design, several lactam forming methods were developed (Figure 3). Alkylidene 
lactams were synthesized from alkynyl formamides through rhodium-catalyzed hydroamidation14 and 
palladium-catalyzed cyanoamidation.15 Replacement of the alkyne with an alkene led to the formation of 
α,α-disubstituted lactams: a palladium-catalyzed Heck-type reaction proceeded from alkenyl 
chloroformamides to give α-vinyl lactams.16 As part of these studies, the reaction of alkenyl 
cyanoformamides with palladium catalyst was found to give α-cyanomethyl lactams. This reaction was 
applied to the synthesis of 3,3-disubstituted oxindoles and other α,α-disubstituted lactams and was 
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Figure 3. Transition-metal-catalyzed lactam formations studied in our group. 
 
During the period when we were studying cyanoamidation, other carbocyanation reactions were 
developed extensively.18 Nishihara’s group and Hiyama’s group reported cyanoesterification of 
norbornenes and allenes.19,20 Hiyama also achieved a series of carbocyanation reactions through C-CN 
bond activation of aryl,21 alkynyl,22 allyl,23 and alkyl21b cyanides. Recently, intramolecular 
enantioselective arylcyanation has been achieved.24 
 
2. Results and Discussion 
2.1. Pd-Catalyzed Intramolecular Cyanoamidation of Olefins 
Cyanoformamide 1a25 derived from commercially available 2-isopropenylaniline was treated with 
palladium catalyst in xylene at 130 oC (Table 1). Treatment of 10 mol % Pd(PPh3)4, under similar reaction 
conditions to these investigated for the intramolecular cyanoamidation of alkynes,15 gave the desired 
3-cyanomethyl-3-methyloxindole 2a in quantitative yield after 15 min (entry 1). When the catalyst 
loading was reduced to 2 mol %, the reaction took 6 h to reach completion (entry 2). Interest in the 
reactivity profile of the ligand prompted us to test a variety of phosphine and phosphorus ligands in 
combination with 2 mol % Pd(dba)2. As a result, it was found that the catalyst generated from P(t-Bu)3 
was extremely reactive. The cyanoformamide 1a was converted to oxindole 2a in 98% yield after 15 min 
even at 100 oC (entry 4). Further decrease of the temperature to 80 oC led to incomplete conversion (entry 
5). In contrast to those relatively strongly donating monophosphorus ligands such as PPh3 and P(t-Bu)3, 
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the conditions using weaker donating ligands (entries 6−8) and bisphosphorus ligands (entries 9−12) 
resulted in poor conversion. 
 




















1 Pd(PPh3)4 (10) 0.25 98 
2 Pd(PPh3)4 (2) 6 quant 
3 Pd(dba)2 (2), PPh3 (4) 2 97 
4b Pd(dba)2 (2), P(t-Bu)3 (4)c 0.25 98 
5d Pd(dba)2 (2), P(t-Bu)3 (4)c 69 74 (16) 
6 Pd(dba)2 (2), P(2-furyl)3 (4) 24 66 (33) 
7 Pd(dba)2 (2), P(OPh)3 (4) 24 58 (42) 
8 Pd(dba)2 (2), 
(t-BuO)2PN(i-Pr)2 (4) 
24 16 (63) 
9 Pd(dba)2 (2), BINAP (2) 24 6 (91) 
10 Pd(dba)2 (2), dppb (4) 24 44 (45) 
11 Pd(dba)2 (2), dppp (4) 24 11 (78) 
12 Pd(dba)2 (2), dppf (4) 24 78 (21) 
a The values in parentheses show the yield of recovered starting materials. 
b Reaction was performed at 100 oC. 
c P(t-Bu)3 was generated from HBF4•P(t-Bu)3 and Et3N in situ.26 
d Reaction was performed at 80 oC. 
 
A variety of oxindoles were synthesized using 2 mol % Pd(dba)2 and 4 mol % P(t-Bu)3 at 100 oC (Table 
2). Most of the cyanoformamides were converted to the corresponding oxindoles in 15 min. The 
substituent R2 on the vinyl group did not affect the reaction significantly, so a variety of oxindoles 
possessing different types of side chains has been made available (entries 1−7). An exception was the 
reaction of cyanoformamide 1e that required higher temperature and longer reaction time (entries 4 and 5). 
In particular, among the products, oxindoles 2e and 2f with two distinct functionalized side chains, 
namely cyanomethyl and silyloxyalkyl, possess high utility as synthetic intermediates for natural and 
synthetic targets. Indeed, a compound related to oxindole 2f was used as a key intermediate for synthetic 
studies on vincorine by our group.27 This reaction also tolerated substitution on the aromatic ring, which 




Table 2. Synthesis of 3,3-disubstituted oxindoles. 






















1b!i 2b!i  
substrate 
entry 
 R1 R2 R3 
yield 
(%) 
1 1b Bn n-Pr H 96 
2 1c Bn i-Pr H 90 
3 1d Bn Ph H quant 
4a 1e Bn CH2OTBS H 74 
5b 1e Bn CH2OTBS H 90 
6 1f Me CH2CH2OTBS H 98 
























a The reaction was allowed to run for 60 h and 12% of 1e was recovered. 
b The reaction was performed at 130 oC for 6 h. 
 
At present, the substituent on the amide nitrogen is limited to alkyl groups due to the low stability of the 
corresponding primary cyanoformamides and difficulty in the synthesis of other derivatives. However, it 
is worth noting that a methyl group on oxindole nitrogen is known to be cleaved under oxidative 
conditions.28 Thus, oxindoles not substituted on the amide nitrogen are available through cyanoamidation 

































Scheme 1. Oxidative demethylation of the cyclized product.29 
 
This intramolecular cyanoamidation was not limited to oxindole formation (Table 3). When pyridine 
derivative 5 was treated with 10 mol % Pd(PPh3)4 (conditions A), azaoxindole 6 was isolated in 97% 
yield after 1 h (entry 1). Conditions B using P(t-Bu)3 unexpectedly did not enable this transformation; 
cyclized product 6 was obtained in only 7% yield even after 24 h, and 71% of the starting material was 
recovered (entry 2). It is apparent that under both conditions cyanoformamide 5 reacted more slowly than 
1a. This difference likely comes from the presence of the nitrogen attached closely to the reaction site. 
Although such nitrogen atoms are known to promote some transition-metal-catalyzed reactions by 
functioning as a directing group,30 negative effects showed up in the case of 5. All the substrates tested 
had a rigid aromatic framework that brings the two reaction sites close. Next, N-butenyl cyanoformamide 
7 with a flexible framework was tested. As a result, 7 gave the corresponding cyanomethyl-γ-lactam 8 in 
95% yield by treatment of 10 mol % Pd(PPh3)4 (entry 3). The catalyst generated with P(t-Bu)3 gave no 
product (entry 4). Furthermore, 6-membered lactam 10 and 7-membered lactam 12 were obtained from 
the reaction with 10 mol % Pd(PPh3)4 (entries 5 and 7). Obviously, the Pd(dba)2−P(t-Bu)3 system 
(conditions B) was not effective for all the compounds in Table 3. We hypothesize that this system 
generates reactive but unstable catalytic species with short lifetimes, which are sensitive to neighboring 
heteroatoms (for 5) or are not sufficiently stable to promote the cyclization of the substrates that require 
large conformational changes (for 7, 9 and 11). Nevertheless, this intramolecular cyanoamidation strategy 
















entry substrate product conditionsa time (h) yield (%) 
recovery of 
SM (%) 











6  B 24 7 71 










8  B 24 0 89 










10  B 24 0 92 












B 24 0 94 
a Conditions A: Pd(PPh3)4 (10 mol %) at 130 oC; Conditions B: Pd(dba)2 (2 mol %), P(t-Bu)3 (4 mol %), 
at 100 oC. 
 
 
2.2 Enantioselective Synthesis of 3,3-Disubstituted Oxindoles 
Next, we studied the enantioselective version of this intramolecular cyanoamidation (Table 4). We started 
the investigation with optically active monophosphorus ligands according to the results shown in Table 1. 
Initial attempts were made with well-known phosphine derivatives such as NMDPP (L1)31 and MOP 
(L2)32 with 2 mol % Pd(dba)2 in xylene at 130 oC (entries 1 and 2). As expected, these electron rich 
ligands promoted the reaction efficiently to give oxindole 2a in quantitative yields after 15 min, but only 
slight enantioselectivity was observed. Phosphonite L333 and phosphonic diamide L434 promoted the 
reaction poorly, and no enantioselectivity was detected (entries 3 and 4). However, the reaction with 
phosphoramidite L535 synthesized from BINOL and dimethylamine gave (S)-oxindole 2a in 80% isolated 
yield and 16% ee (entry 5). It was found that the size of the amino group significantly affected the 
enantioselectivity. The selectivity increased from 16% ee to 26% ee when dimethylamine was changed to 
morpholine (entry 6).36 Phosphoramidite L736 derived from bulkier diisopropylamine gave 46% ee, and 
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finally phosphoramidite L837 with the bis[(R)-1-phenylethyl]amino group resulted in 69% ee with 96% 
isolated yield (entries 7 and 8). Changing the configuration of BINOL from R to S gave (R)-2a as a major 
product with lower selectivity and yield (entry 10). Phosphoramidites L9,37 L11,38 L12,39 and L1340 
derived from dimethyl BINOL, biphenol, spirobiindane diol, and TADDOL, respectively, unexpectedly 
resulted in higher reactivity than L8 but poorer selectivity (entries 9, 11−13). Bisphosphorus ligands L14, 
L1541 and L1642 gave poor conversion and selectivity (entries 14−16).  
 

















time (h) yield 
(%)a 
ee (%) 
1 L1 (4) 0.25 98 7 (R) 
2 L2 (4) 0.25 quant 9 (R) 
3 L3 (4) 24 26 (70) 0 
4 L4 (4) 24   4 (87) 0 
5 L5 (4) 24 80 16 (S) 
6 L6 (4) 8 97 26 (S) 
7 L7 (4) 24 65 46 (S) 
8 L8 (8) 6 96 69 (S) 
9 L9 (8) 0.25 quant  16 (S) 
10 L10 (8) 24 76 25 (R) 
11 L11 (8) 0.25 93 15 (S) 
12 L12 (8) 0.25 97 44 (S) 
13 L13 (2) 3 95 32 (S) 
14 L14 (2) 24 6 (91) 0 
15 L15 (2) 48 33 (58) 5 (S) 
16 L16 (2) 48 51 (38) 31 (S) 






















L5 (NR12 = NMe2)
L7 (NR12 = N
iPr2)










L8 (R2 = H)
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The effects of solvents and additives were examined with using 2 mol % Pd(dba)2 and 8 mol % 
phosphoramidite L8 (Table 5). When polar N-methyl-2-pyrrolidone (NMP) was used as the solvent, the 
reaction rate was markedly increased so that it reached completion in 15 min, but the selectivity dropped 
to 56% ee (entry 2). The reaction in less-polar decalin gave better selectivity but poorer conversion (entry 
3). To achieve good selectivity and conversion, a polar additive was employed in the reaction in decalin. 
Addition of 100 mol % of NMP resulted in completion of the reaction in 2 h to give quantitative yield and 
78% ee (entry 4). The amount of NMP was reduced to 8 mol % and 2 mol % but the effect remained 
comparable (entries 5 and 6). Next, the reaction temperature was reduced to 100 oC in the hope of 
enhancing the stereoselectivity. However, the reaction was not completed in 24 h even with 100 mol % of 
NMP (entry 7). The more donating 1,3-dimethyl-2-imidazolidinone (DMI) was found to bring the 
reaction to completion (entry 8), and at the end, addition of N,N-dimethylpropylene urea (DMPU) gave 
quantitative yield and 81% ee (entry 9). It is worth noting that other Lewis bases such as 
4-(N,N-dimethylamino)pyridine (DMAP) or hexamethylphosphorus triamide (HMPT) had no activation 
effect at all. Several possibilities for the effects of additive can be suggested: for example, i) accelerating 
formation of the reactive complex from Pd(dba)2 and phosphoramidite, and ii) stabilizing the 
coordinatively unsaturated species during the catalytic cycle. Additionally, we wish to propose other roles 
by noting the structural similarity of the effective additives and the reaction product: both have an amide 
or a urea functionality. After reductive elimination, the product must be cleaved from the palladium 
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complex to induce the next catalytic cycle. However, the cyanomethyl oxindole should complex tightly to 
palladium, particularly in nonpolar solvents. Lewis base additives may promote this decomplexation.43 
 








Pd(dba)2 (2 mol %)
1a (S)-2a
additive, solvent
L8 (8 mol %)
 
entry solvent additive (mol %) temp (oC) time (h) yield (%) ee (%)a recovery of SM 
(%) 
1 xylene - 130 6 96 69 - 
2 NMP - 130 0.25 97 56 - 
3 decalin - 130 24 83 74  10 
4 decalin NMP (100) 130 2 quant 78 - 
5 decalin NMP (8) 130 3 98 76 - 
6 decalin NMP (2) 130 3 97 76 - 
7 decalin NMP (100) 100 24 85 80 15 
8 decalin DMI (100) 100 24 97 79 - 
9 decalin DMPU (100) 100 24 quant 81 - 
a The major enantiomer was the S-isomer in all reactions. 
 
Optically active 3,3-disubstituted oxindoles were synthesized under the conditions determined (Table 6). 
The substituent R2 on the vinyl group did not affect the reaction rate and yield in these enantioselective 
reactions but did affect their stereoselectivity (entries 1−5). An increase in bulkiness (Me < n-Pr < 
CH2OTBS < i-Pr ≈ Ph) resulted in a decrease in selectivity. N-Methyl cyanoformamide 1g gave slightly 
lower selectivity than 1a (entry 6). Substitution on the aromatic ring did not affect enantioselectivity but 
unexpectedly changed the reactivity. An increased amount of catalyst was required to complete the 
reaction of 1j and 1k that have methoxy groups (entries 9, 10). The reaction of cyanoformamide 1l with a 






Table 6. Synthesis of optically active 3,3-disubstituted oxindoles. 
Pd(dba)2 (2 mol %)
L8 (8 mol %)



























1 1a Bn Me H quant 81 
2 1b Bn n-Pr H quant 72 
3 1c Bn i-Pr H 96 60 
4 1d Bn Ph H quant 61 
5 1e Bn CH2-OTBS H 72 68 






































a Pd(dba)2 (5 mol %) and L8 (20 mol %) was used. b Pd(dba)2 (5 mol %) and L8 (10 mol %) was used. 
 
The conditions described were applied to the cyclization of aliphatic cyanoformamide 7 without 
modification (Scheme 2). Unfortunately, the starting material was not consumed completely after 24 h 
even at 130 oC, and its selectivity was only 27% ee. Better conditions for enantioselective access to 
α,α-disubstituted lactams are being explored. 
Pd(dba)2 (2 mol %)
L8 (8 mol %)

















Scheme 2. Enantioselective cyclization of cyanoformamide 7. 
 
2.3. Mechanistic Considerations 
Although not much information is available on the reaction mechanism, we believe that the reaction 
proceeds through oxidative addition of the CO−CN bond to palladium(0), followed by amidopalladation 
and reductive elimination (Figure 4). The alternative cyanopalladation pathway (C→E), which may give 
the same final product, has been excluded by previous studies.15 We propose that the oxidative addition of 
the CO−CN bond forms the four-coordinate intermediate C prior to insertion. Other pathways through the 
five-coordinate complex F or cationic complex G are unlikely, because the reaction is catalyzed 
effectively by large unidentate ligands and not by bidentate ligands. There are clear contrasts in terms of 
effective ligands between this reaction and other related enantioselective 3,3-disubstituted oxindole and 
indoline formations starting from allyl amine derivatives H. These reactions proceed efficiently in the 
presence of optically active bidentate ligands. For example, the palladium-catalyzed enantioselective 
Heck reaction studied by Overman et al. gave the best result with BINAP, and the reaction pathway 
containing a five-coordinate complex and a cationic complex like F and G were proposed.2b More 
recently, enantioselective arylation-cyanation reactions3 and nickel catalyzed enantioselective 

































































X = I orCN
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2.4. Synthetic Manipulations of 3,3-Disubstituted Oxindoles 
With the highly substituted oxindoles in hand, we studied synthetic manipulations of this class of 
compounds with the aim of providing drug-like structural motifs and realizing efficient access to natural 
products. Our approach illustrated in Figure 5 takes advantage of the presence of the cyano group 
incorporated by the cyanoamidation. Connection between the cyano group and substituent R2 on the 
quaternary carbon gives spirooxindole A. On the other hand, ring formation between the cyano group and 































Figure 5. Strategy for the access to higher-ordered structures. 
 
The first example is the synthesis of spirolactam 15 (Scheme 3). Starting from oxindole 2f, removal of the 
TBS group followed by sequential oxidation and methylation gave cyanoester 14. This compound was 
cyclized through selective reduction of the cyano group by CoCl2•6H2O and NaBH4, followed by 





































Scheme 3. Synthesis of spirolactam 15. 
 
On the other hand, pyrroloindole 17 can also be formed in simple steps from oxindole 2a (Scheme 4). 
Again the selective reduction of the cyano group was achieved by CoCl2•6H2O and NaBH4. Subsequent 
14 
 
methoxycarbonylation gave carbonate 16. This compound was reductively cyclized to give pyrroloindole 
17.45 Comparison of the optical rotation of 17 with that reported in the literature showed that oxindole 2a 
































Scheme 4. Synthesis of pyrroloindole 17. 
 
3. Conclusions 
The palladium catalyzed intramolecular cyanoamidation of olefins was reported and shown to be an 
efficient strategy toward the synthesis of 3,3-disubstituted oxindoles as well as other α,α-disubstituted 
lactams. Electron rich phosphine ligands were found to promote this reaction smoothly. In particular, the 
catalyst generated from Pd(dba)2 and P(t-Bu)3 gave desired oxindoles in 15 min at 100 oC. On the other 
hand, Pd(PPh3)4 provided better results for the synthesis of other α,α-disubstituted lactams. Efforts to 
expand this reaction to enantioselective conversions resulted in the finding that a catalytic amount of 
Pd(dba)2 and the phosphoramidite derived from (R)-BINOL and bis[(R)-1-phenylethyl]amine gave high 
yields and high enantioselectivity. The addition of DMPU was crucial to achieve the best results. This 
progress enables quick access to a variety of oxindoles and related compounds in a convenient manner. 
 
4. Experimental Section 
4.1. General.  
Unless otherwise noted, all reactions were performed under argon. Pd(PPh3)4 was 
prepared by using the reported protocol.47 Pd(dba)2 was purchased from Tokyo 
Chemical Industry Co., Ltd. N,N'-Dimethyl propylene urea (DMPU) was distilled from 
CaH2. L8 and other optically active phosphoramidite ligands were prepared according 
to the literature procedure.48 Silica gel column chromatography was performed with 
Kanto silica gel 60 (particle size, 63–210 µm). Proton nuclear magnetic resonance (1H 
NMR) spectra were recorded on a JEOL JNM-LA 500 at 500 MHz or a JEOL JNM-AL 
400 at 400 MHz. Chemical shifts are reported relative to Me4Si (δ 0.00). Multiplicity is 
indicated by one or more of the following: s (singlet); d (doublet); t (triplet); q (quartet); 
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m (multiplet); br (broad). Carbon nuclear magnetic resonance (13C NMR) spectra were recorded on a 
JEOL JNM-LA 500 at 126 MHz or a JEOL JNM-AL 400 at 100 MHz. Chemical shifts are reported 
relative to CDCl3 (δ 77.0). Infrared spectra were recorded on a FT/IR-4100 (JASCO) equipped with an 
attenuated total reflection (ATR) attachment or on a FT/IR-410 (JASCO) as a thin film on NaCl plate 
(thin film) or as a KBr pellet (KBr) or as a CHCl3 solution (CHCl3). Optical rotations were measured with 
a JASCO DIP-360 digital polarimeter. Enantiomer ratios were determined by chiral HPLC 
using a Shimadzu SPD-10A with Daicel Chemical Industries, LTD. Chiralpak AD-H 
(0.46 cm x 25 cm), Chiralpak OJ-H (0.46 cm x 25 cm), Chiralpak OD-H (0.46 cm x 25 cm), 
or Chiralpak AS-H (0.46 cm x 25cm). 
 
4.2. Preparation of Cyanoformamides49 
4.2.1. Cyanoformamide 1a: To a solution of N-benzyl-2-(prop-1-en-2-yl)aniline (3.20 g, 14.6 mmol) in 
CH2Cl2 (30 mL) was added pyridine (1.77 mL, 21.9 mmol) followed by triphosgene (1.51 g, 5.10 mmol) 
at –78 ºC. The reaction mixture was warmed to room temperature, diluted with CHCl3, and washed with 1 
M HCl and brine. The organic phase was dried over MgSO4, filtered, and concentrated under reduced 
pressure to give the crude chloroformamide. To a solution of this crude chloroformamide in MeCN (25 
mL) and t-BuOH (5.0 mL) were added 18-crown-6 (392 mg, 1.46 mmol) and KCN (1.43 g, 21.9 mmol), 
and the resulting mixture was stirred at 60 ºC for 2 h. After removal of the solvents, water was added, and 
the mixture was extracted with CHCl3. The combined organic extracts were dried over MgSO4, filtered, 
and concentrated under reduced pressure. The residue obtained was purified by silica gel column 
chromatography (hexane/EtOAc = 95/5) to give oxindole 1a (3.83 g, 95% over 2 steps) as a colorless oil: 
1H NMR (500 MHz, CDCl3, δ) 7.40 (dd, 1H, J1 = J2 = 7.6 Hz), 7.37 (dd, 1H, J1 = 1.5, J2 = 7.6 Hz), 
7.31–7.25 (m, 3H), 7.19 (dd, 1H, J1 = J2 = 7.6 Hz), 7.15–7.13 (m, 2H), 6.75 (d, 1H, J = 7.6 Hz), 6.66* (d, 
J = 7.7 Hz), 5.50 (d, 1H, J = 14.3 Hz), 5.35 (s, 1H), 5.26* (s), 5.08 (s, 1H), 4.96* (s), 4.09 (d, 1H, J = 
14.3 Hz), 2.12 (s, 3H), 2.05* (s); 13C NMR (126 MHz, CDCl3, δ) 145.7, 142.4, 142.2, 135.1, 134.8, 130.7, 
130.6, 130.5, 130.0*, 129.5, 129.3*, 129.1*, 128.9, 128.6, 128.5, 118.4, 116.8*, 111.0, 52.4, 23.7; IR 
(CHCl3) 2231, 1677 cm–1; MS (EI) m/z = 276 (M+); Anal. Calcd for C18H16N2O: C, 78.24; H, 5.84; N, 
10.14. Found: C, 78.35; H, 5.91; N, 10.02. (* Peaks of minor rotamer) 
 
4.3. General Procedure for Pd-Catalyzed Cyanoamidation 
4.3.1. Conditions using 10 mol % Pd(PPh3)4 (Table 1, entry 1): A solution of cyanoformamide 1a (100 
mg, 0.362 mmol) and Pd(PPh3)4 (41.8mg, 0.0362 mmol) in xylene (3.6 mL) was stirred at 130 ºC for 0.25 
h. The mixture was subjected directly to silica gel column chromatography (hexane/EtOAc = 10/0→8/2) 
to give the oxindole 2a (98.2 mg, 98%) as a colorless oil. 1H NMR (500 MHz, CDCl3, δ) 7.48 (d, 1H, J = 
7.6 Hz), 7.34–7.25 (m, 5H), 7.23 (dd, 1H, J1 = J2 = 7.6 Hz), 7.09 (dd, 1H, J1 = J2 = 7.6 Hz), 6.78 (d, 1H, J 
= 7.6 Hz), 4.95 (d, 1H, J = 16.5 Hz), 4.92 (d, 1H, J = 16.5 Hz), 2.91 (d, 1H, J = 16.8 Hz), 2.64 (d, 1H, J = 
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16.8 Hz), 1.57 (s, 3H); 13C NMR (126 MHz, CDCl3, δ) 177.9, 142.0, 135.5, 131.2, 129.3, 129.1, 128.0, 
127.4, 123.5, 123.4, 116.8, 109.9, 45.1, 44.1, 26.4, 22.6; IR (CHCl3) 1714 cm–1; MS (EI) m/z = 276 (M+); 
Anal. Calcd for C18H16N2O: C, 78.24; H, 5.84; N, 10.14. Found: C, 78.18; H, 6.06; N, 10.12. 
4.3.2. Conditions using 2 mol % Pd(dba)2 and 4 mol % P(t-Bu3) (Table 1, entry 4): A solution of 
cyanoformamide 1a (100 mg, 0.362 mmol), Pd(dba)2 (4.16 mg, 0.00724 mmol), P(t-Bu3)•HBF4 (4.20 mg, 
0.0145 mmol), and Et3N (5.08 µL, 0.0362 mmol) in xylene (3.6 mL) was stirred at 100 ºC for 0.25 h. The 
mixture was subjected directly to silica gel column chromatography (hexane/EtOAc = 10/0→8/2) to give 
the oxindole 2a (98.4 mg, 98%). 
4.3.3. Enantioselective cyanoamidation (Table 5, entry 9): A solution of cyanoformamide 1a (100 mg, 
0.362 mmol), L8 (15.6 mg, 0.0290 mmol), DMPU (0.043 mL, 0.36 mmol), and Pd(dba)2 (4.2 mg, 0.0072 
mmol) in decalin (3.6 mL) was stirred at 100 ºC for 24 h. The mixture was subjected directly to silica gel 
column chromatography (hexane/EtOAc = 10/0→8/2) to give the oxindole 2a (99.4 mg, quant). HPLC 
[Chiralcel OD-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 14.3 min, 
(major) 17.5 min]; [α]26D 26.9 (c = 0.90 in CHCl3, 81% ee). 
4.3.4. Oxindole 2b: Colorless oil; 1H NMR (500 MHz, CDCl3, δ) 7.42 (dd, 1H, J1 = 0.9 Hz, J2 =7.6 Hz), 
7.33–7.25 (m, 5H), 7.23 (dd, 1H, J1 = J2 = 7.6 Hz), 7.10 (ddd, 1H, J1 = 0.9 Hz, J2 = J3 = 7.6 Hz), 6.78 (d, 
1H, J = 7.6 Hz), 4.96 (d, 1H, J = 15.6 Hz), 4.90 (d, 1H, J = 15.6 Hz), 2.87 (d, 1H, J = 16.8 Hz), 2.65 (d, 
1H, J = 16.8 Hz), 2.02 (ddd, 1H, J1 = 5.2 Hz, J2 = 10.7 Hz, J3 = 13.1 Hz), 1.98 (ddd, 1H, J1 = 5.2 Hz, J2 = 
10.7 Hz, J3 = 13.1 Hz), 1.08 (m, 1H), 0.90 (m, 1H), 0.82 (dd, 3H, J1 = J2 = 7.3 Hz); 13C NMR (126 MHz, 
CDCl3, δ) 177.4, 142.8, 135.6, 129.5, 129.2, 129.0, 128.0, 127.5, 123.44, 123.41, 116.7, 109.8, 49.3, 44.2, 
38.7, 26.3, 17.6, 14.0; IR (thin film) 1712 cm–1; MS (EI) m/z = 304 (M+); HPLC [Chiralcel OD-H, 
hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 10.5 min, (major) 13.1 
min]; [α]26D 26.7 (c = 0.78 in CHCl3, 72% ee). 
4.3.5. Oxindole 2c: Colorless oil; 1H NMR (500 MHz, CDCl3, δ) 7.37 (dd, 1H, J1 = 0.9, J2 = 7.7Hz), 
7.33–7.25 (m, 5H), 7.24 (ddd, 1H, J1 = 1.2 Hz, J2 = J3 = 7.7 Hz), 7.08 (ddd, 1H, J1 = 0.9 Hz, J2 = J3 = 7.7 
Hz), 6.78 (d, 1H, J = 7.6 Hz), 4.98 (d, 1H, J = 15.5 Hz), 4.88 (d, 1H, J = 15.5 Hz), 2.98 (d, 1H, J = 16.4 
Hz), 2.74 (d, 1H, J = 16.4 Hz), 2.44–2.31 (m, 1H), 0.97 (d, 3H, J = 7.1 Hz), 0.92 (d, 3H, J = 7.1 Hz); 13C 
NMR (126 MHz, CDCl3, δ) 176.9, 143.0, 135.4, 129.0, 128.9, 128.8, 127.7, 127.3, 123.5, 122.9, 116.6, 
109.4, 52.1, 43.9, 34.4, 23.9, 17.1, 16.8; IR (thin film) 2360, 1711 cm–1; MS (EI) m/z = 304 (M+); Anal. 
Calcd for C20H20N2O: C, 78.92; H, 6.62; N, 9.20. Found: C, 78.66; H, 6.52; N, 9.24.; HPLC [Chiralcel 
OD-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 12.0 min, (major) 
16.0 min, 60% ee]. 
4.3.6. Oxindole 2d: Colorless oil; 1H NMR (500 MHz, CDCl3, δ) 7.41 (d, 1H, J = 7.7 Hz), 7.28–7.13 (m, 
11H), 7.07 (ddd, 1H, J1 = 1.0, J2 = J3 = 7.7 Hz), 6.75 (d, 1H, J = 7.7 Hz), 4.82 (d, 1H, J = 15.9 Hz), 4.86 
(d, 1H, J = 15.9 Hz), 3.33 (d, 1H, J = 16.5 Hz), 3.05 (d, 1H, J = 16.5 Hz); 13C NMR (126 MHz, CDCl3, δ) 
176.0, 142.7, 136.7, 135.1, 129.6, 129.0, 128.9, 128.4, 127.8, 127.1, 126.7, 125.2, 123.4, 116.4, 110.1, 
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52.7, 44.1, 26.1; IR (ATR) 2353, 1716 cm–1; MS (EI) m/z = 338 (M+); Anal. Calcd for C23H18N2O: C, 
81.63; H, 5.36; N, 8.28. Found: C, 81.43; H, 5.49; N, 8.01.; HPLC [Chiralcel OD-H, hexane/2-propanol = 
70/30, 1.0 mL/min, λ = 210 nm, retention times: (minor) 9.3 min, (major) 13.4 min, 61% ee]. 
4.3.7. Oxindole 2e: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.53 (d, 1H, J = 7.7 Hz), 7.38–7.32 (m, 
5H), 7.28 (dd, 1H, J1 = J2 = 7.7 Hz), 7.14 (dd, 1H, J1 = J2 = 7.7 Hz), 6.81 (d, 1H, J = 7.7 Hz), 5.02 (d, 1H, 
J = 16.7 Hz), 4.98 (d, 1H, J = 16.7 Hz), 4.07 (d, 1H, J = 9.5 Hz), 3.93 (d, 1H, J = 9.5 Hz), 3.10 (d, 1H, J = 
16.5 Hz), 2.86 (d, 1H, J = 16.5 Hz), 0.87 (s, 9H), 0.06 (s, 3H), 0.00 (s, 3H); 13C NMR (100 MHz, CDCl3, 
δ) 175.7, 143.1, 135.4, 129.4, 129.0, 128.5, 127.9, 127.3, 124.3, 123.1, 116.6, 109.7, 66.8, 51.2, 44.1, 
25.7, 21.8, 18.2, –5.5, –5.7; IR (thin film) 2353, 1716 cm–1; MS (EI) m/z = 406 (M+); Anal. Calcd for 
C24H30N2O2Si: C, 70.90; H, 7.44; N, 6.89. Found: C, 70.61; H, 7.46; N, 6.78.; HPLC [Chiralcel OD-H, 
hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 6.7 min, (major) 8.2 min]; 
[α]26D –5.2 (c = 0.83 in CHCl3, 68% ee). 
4.3.8. Oxindole 2f: Colorless oil; 1H NMR (400 MHz, CDCl3, δ); 7.43 (d, 1H, J = 7.8 Hz), 7.36 (dd, 1H, 
J1 = J2 = 7.8 Hz), 7.13 (dd, 1H, J1 = J2 = 7.8 Hz), 6.89 (d, 1H, J = 7.8 Hz), 3.51–3.39 (m, 2H), 3.22 (s, 
3H), 2.92 (d, 1H, J = 16.6 Hz), 2.58 (d, 1H, J = 16.6 Hz), 2.32–2.25 (m, 1H), 2.20–2.15 (m, 1H), 0.77 (s, 
9H), –0.12 (s, 3H), –0.13 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 177.1, 143.8, 129.4, 128.9, 123.9, 
123.1, 116.9, 108.8, 59.2, 47.5, 37.9, 26.8, 26.6, 25.9, 18.3, –5.64; IR (CHCl3) 2251, 1719 cm−1; MS 
(FAB) m/z = 345 (M+H+); Anal. Calcd for C19H28N2O2Si: C, 66.24; H, 8.19; N, 8.13. Found: C, 65.91; H, 
8.19; N, 8.04. 
4.3.9. Oxindole 2g: Colorless oil; 1H NMR (500 MHz, CDCl3, δ) 7.48 (d, 1H, J = 8.0 Hz), 7.36 (dd, 1H, 
J1 = J2 = 8.0 Hz), 7.14 (dd, 1H, J1 = J2 = 8.0 Hz), 6.92 (d, 1H, J = 8.0 Hz), 3.25 (s, 3H), 2.85 (d, 1H, J = 
16.4 Hz), 2.58 (d, 1H, J = 16.4 Hz), 1.53 (s, 3H); 13C NMR (126 MHz, CDCl3, δ) 177.7, 142.9, 131.2, 
129.3, 123.4, 123.3, 116.8, 108.8, 44.9, 26.6, 26.3, 22.2; IR (thin film) 1715 cm–1; MS (EI) m/z = 200 
(M+); Anal. Calcd for C12H12N2O: C, 71.98; H, 6.04; N, 13.99. Found: C, 71.70; H, 6.08; N, 13.85.; 
HPLC [Chiralcel AD-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 
8.4 min, (major) 9.6 min]; [α]26D 63.6 (c = 0.93 in CHCl3, 75% ee). 
4.3.10. Oxindole 2h: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.32–7.23 (m, 6H), 7.01 (d, 1H, J = 
7.8 Hz), 6.66 (d, 1H, J = 7.8 Hz), 4.91 (s, 2H), 2.88 (d, 1H, J = 16.5 Hz), 2.63 (d, 1H, J = 16.5 Hz), 2.32 
(s, 3H), 1.56 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 177.8, 139.6, 135.6, 133.1, 131.2, 129.5, 129.0, 
127.9, 127.3, 124.1, 116.8, 109.6, 45.0, 44.0, 26.3, 22.6, 21.1; IR (thin film) 1712 cm–1; MS (EI) m/z = 
290 (M+); Anal. Calcd for C19H18N2O: C, 78.59; H, 6.25; N, 9.65. Found: C, 78.55; H, 6.41; N, 9.53.; 
HPLC [Chiralcel OD-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 
11.4 min, (major) 15.1 min]; [α]26D 22.9 (c = 1.38 in CHCl3, 74% ee). 
4.3.11. Oxindole 2i: Colorless solid; mp. 96.5–97.2 ºC; 1H NMR (400 MHz, CDCl3, δ) 7.39 (d, 1H, J = 
7.8 Hz), 7.37–7.28 (m, 5H), 7.08 (dd, 1H, J1 = 1.7 Hz, J2 = 7.8 Hz), 6.78 (d, 1H, J = 1.7 Hz), 4.90 (s, 2H), 
2.89 (d, 1H, J = 16.6 Hz), 2.63 (d, 1H, J = 16.6 Hz), 1.57 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 177.9, 
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143.3, 135.3, 135.0, 129.5, 129.3, 128.3, 127.4, 124.4, 123.5, 116.5, 110.6, 44.9, 44.2, 26.4, 22.6; IR 
(KBr) 1680 cm–1; MS (EI) m/z = 310 (M+); Anal. Calcd for C18H15ClN2O: C, 69.57; H, 4.86; N, 9.01. 
Found: C, 69.58; H, 5.10; N, 9.14.; HPLC [Chiralcel OD-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 
210 nm, retention times: (minor) 16.7 min, (major) 22.4 min]; [α]26D 12.2 (c = 0.17 in CHCl3, 82% ee). 
4.3.12. Oxindole 2j: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.35–7.27 (m, 5H), 7.07 (s, 1H), 6.36 
(s, 1H), 4.92 (s, 2H), 3.87 (s, 3H), 3.74 (s, 3H), 2.89 (d, 1H, J = 16.6 Hz), 2.61 (d, 1H, J = 16.6 Hz), 1.56 
(s, 3H); 13C NMR (100 MHz, CDCl3, δ) 178.3, 150.4, 146.0, 135.7, 129.18, 129.17, 128.1, 127.4, 121.9, 
117.0, 108.3, 96.1, 57.0, 56.4, 45.3, 44.2, 26.7, 22.7; IR (thin film) 1710 cm–1; MS (EI) m/z = 336 (M+); 
Anal. Calcd for C20H20N2O3: C, 71.41; H, 5.99; N, 8.33. Found: C, 71.18; H, 6.03; N, 8.27.; HPLC 
[Chiralcel AS-H, hexane/2-propanol = 90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 40.2 min, 
(major) 47.3 min]; [α]26D 36.4 (c = 0.98 in CHCl3, 82% ee). 
4.3.13. Oxindole 2k:  Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.33–7.26 (m, 5H), 7.08 (d, 1H, J = 
2.5 Hz), 6.74 (dd, 1H, J1 = 2.5 Hz, J2 = 8.5 Hz), 6.67 (d, 1H, J = 8.5 Hz), 4.90 (s, 2H), 3.77 (s, 3H), 2.89 
(d, 1H, J = 16.6 Hz), 2.65 (d, 1H, J = 16.6 Hz), 1.56 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 177.6, 156.7, 
135.6, 135.3, 132.5, 129.1, 128.0, 127.4, 116.7, 113.7, 110.7, 110.4, 55.9, 45.4, 44.1, 26.4, 22.6; IR (thin 
film) 1712 cm–1; MS (EI) m/z = 306 (M+); HPLC [Chiralcel AD-H, hexane/2-propanol = 90/10, 1.0 
mL/min, λ = 210 nm, retention times: (minor) 16.7 min, (major) 19.1 min]; [α]26D 13.7 (c = 1.11 in CHCl3, 
78% ee). 
 
4.3.14. Oxindole 2l: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.24–7.17 (m, 5H), 7.03 (dd, 1H, J1 = 
J2 = 7.8 Hz), 6.77 (d, 1H, J = 7.8 Hz), 6.54 (d, 1H, J = 7.8 Hz), 4.91 (d, 1H, J = 15.8 Hz), 4.84 (d, 1H, J = 
15.8 Hz), 2.98 (d, 1H, J = 16.8 Hz), 2.91 (d, 1H, J = 16.8 Hz), 2.34 (s, 3H), 1.50 (s, 3H); 13C NMR (100 
MHz, CDCl3, δ) 178.0, 142.8, 135.5, 134.6, 129.1, 129.0, 127.9, 127.3, 125.9, 116.30, 116.29, 107.9, 46.8, 
44.1, 24.7, 21.6, 18.4; IR (thin film) 1713 cm–1; MS (EI) m/z = 290 (M+); Anal. Calcd for C19H18N2O: C, 
78.59; H, 6.25; N, 9.65. Found: C, 78.32; H, 6.39; N, 9.53.; HPLC [Chiralcel OD-H, hexane/2-propanol = 
90/10, 1.0 mL/min, λ = 210 nm, retention times: (minor) 15.1 min, (major) 19.6 min]; [α]26D –37.5 (c = 
0.88 in CHCl3, 86% ee). 
4.3.15. Lactam 6: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 8.25 (dd, 1H, J1 = 1.7 Hz, J2 = 5.3 Hz), 
7.73 (dd, 1H, J1 = 1.7 Hz, J2 = 7.3 Hz), 7.44–7.42 (m, 2H), 7.32–7.24 (m, 3H), 7.02 (dd, 1H, J1 = 5.3 Hz, 
J2 = 7.3 Hz), 5.01 (s, 2H), 2.89 (d, 1H, J = 16.6 Hz), 2.53 (d, 1H, J = 16.6 Hz), 1.55 (s, 3H); 13C NMR 
(100 MHz, CDCl3, δ) 177.0, 155.6, 148.2, 136.2, 131.0, 128.6, 128.2, 127.7, 125.2, 118.8, 116.3, 44.3, 
42.8, 25.6, 21.7; IR (ATR) 1722 cm–1; MS (EI) m/z = 277 (M+); Anal. Calcd for C17H15N3O: C, 73.63; H, 
5.45; N, 15.15. Found: C, 73.78; H, 5.67; N, 15.02. 
4.3.16. Lactam 8: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.35–7.27 (m, 3H), 7.22–7.21 (m, 2H), 
4.49 (d, 1H, J = 14.6 Hz), 4.43 (d, 1H, J = 14.6 Hz), 3.24–3.21 (m, 2H), 2.61 (d, 1H, J = 16.8 Hz), 2.57 (d, 
1H, J = 16.8 Hz), 2.12 (ddd, 1H, J1 = J2 = 8.2 Hz, J3 = 13.1 Hz), 1.96 (ddd, 1H, J1 = 5.2 Hz, J2 = 6.4 Hz, 
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J3 = 13.1 Hz), 1.29 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 175.3, 135.8, 128.7, 127.9, 127.6, 117.3, 46.7, 
42.7, 42.5, 30.7, 26.2, 22.1; IR (thin film) 1689 cm–1; MS (EI) m/z = 228 (M+); Anal. Calcd for 
C14H16N2O: C, 73.66; H, 7.06; N, 12.27. Found: C, 73.47; H, 7.22; N, 11.99. 
4.3.17. Lactam 10: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.39–7.25 (m, 8H), 7.09 (d, 1H, J = 7.6 
Hz), 4.86 (d, 1H, J = 14.6 Hz), 4.74 (d, 1H, J = 14.6 Hz), 4.48 (d, 1H, J = 16.3 Hz), 4.41 (d, 1H, J = 16.3 
Hz), 3.28 (d, 1H, J = 16.4 Hz), 2.96 (d, 1H, J = 16.4 Hz), 1.57 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 
170.6, 136.5, 136.2, 130.1, 128.9, 128.3, 127.9, 127.8, 127.5, 125.9, 124.9, 117.6, 50.8, 49.2, 44.6, 27.4, 
26.2; IR (thin film) 2248, 1642 cm–1; MS (EI) m/z = 290 (M+); Anal. Calcd for C19H18N2O: C, 78.59; H, 
6.25; N, 9.65. Found: C, 78.72; H, 6.24; N, 9.63. 
4.3.18. Lactam 12: Colorless oil; 1H NMR (400 MHz, CDCl3, δ) 7.57–6.88 (m, 13H), 5.12 (d, 1H, J = 
15.8 Hz), 5.02 (d, 1H, J = 15.8 Hz), 3.41 (d, 1H, J = 16.1 Hz), 3.24 (d, 1H, J = 16.1 Hz), 2.45* (d, J = 
16.1 Hz), 2.34* (d, J = 16.1 Hz), 2.02* (s), 1.27 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 171.4, 170.2*, 
140.1, 139.9*, 139.4, 138.7*, 137.4*, 137.3, 136.5, 136.4*, 135.6, 135.0*, 130.7, 130.3*, 130.2, 130.0, 
129.5*, 129.2*, 129.1, 129.0, 128.9*, 128.6, 128.5*, 127.2, 126.8*, 126.6, 126.5*, 126.2, 126.0*, 124.1, 
123.1*, 122.5, 119.1, 117.0*, 54.6*, 54.2, 49.0, 48.2*, 28.1, 24.1*24.0*, 20.3; IR (thin film) 1648, 2360 
cm–1; MS (EI) m/z = 352 (M+); Anal. Calcd for C24H20N2O: C, 81.79; H, 5.72; N, 7.95. Found: C, 81.54; 
H, 5.63; N, 7.83. (* Peaks of minor atropisomer) 
 
 
4.4. Synthesis of Spirolactam 15 
4.4.1. Alcohol 13: To a solution of compound 2f (148 mg, 430 µmol) in THF (15 mL) was added 1 M 
TBAF solution in THF (970 µL, 970 µmol) at 0 ºC. After stirring at the same temperature for 30 min, 
water was added, and the mixture was extracted with EtOAc. The combined extracts were washed with 
brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by 
silica gel column chromatography (CHCl3/MeOH = 9/1→6/4) to give 13 (96.8 mg, 98%) as a white solid; 
mp 85.5–85.9 ºC; 1H NMR (400 MHz, CDCl3, δ); 7.46 (d, 1H, J = 7.3 Hz), 7.39 (dd, 1H, J1 = 7.8 Hz, J2 = 
7.5 Hz), 7.16 (dd, 1H, J1 = 7.6 Hz, J2 = 7.5 Hz), 6.93 (d, 1H, J = 7.8 Hz), 3.68–3.61 (m, 1H), 3.50–3.42 
(m, 1H), 3.25 (s, 3H), 2.95 (d, 1H, J = 16.6 Hz), 2.62 (d, 1H, J = 16.6 Hz), 2.37–2.31 (m, 1H), 2.24–2.18 
(m, 1H), 1.72 (br, 1H); 13C NMR (100 MHz, CDCl3, δ); 177.9, 143.5, 129.7, 129.1, 123.7, 123.6, 116.6, 
109.1, 59.0, 47.6, 38.1, 26.8, 26.1; IR (CHCl3) 3347, 2251, 1707, 1613 cm–1; MS (FAB) m/z = 231 
(M+H+); Anal. Calcd for C13H14N2O2: C, 67.81; H, 6.13; N, 12.17. Found: C, 67.64; H, 6.22; N, 12.00. 
4.4.2. Ester 14: To a solution of oxalyl chloride (177 mg, 1.39 mmol) in CH2Cl2 (2 mL) was added 
DMSO (191 mg, 2.44 mmol) in CH2Cl2 (2 mL) at −78 ºC. After stirring for 10 min, a solution of 13 (112 
mg, 0.487 mmol) in CH2Cl2 (2 mL) was added at the same temperature. After stirring for 15 min, Et3N 
(680 µl, 4.88 mmol) was added, and the reaction mixture was warmed to room temperature. After stirring 
for 30 min, the reaction mixture was quenched with 1 M HCl and brine. The mixture was extracted with 
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CHCl3. The combined organic extracts were washed with saturated aqueous NaHCO3 and brine, dried 
over MgSO4, filtered, and concentrated under reduced pressure. The residue was dissolved in t-BuOH (6 
mL) and 2-methyl-2-butene (3 mL). To this solution was added NaClO2 (385 mg, 3.41 mmol) in 
NaH2PO4 buffer solution (1 mM in water, 3.5 mL). After stirring for 30 min, organic solvents were 
concentrated under reduced pressure. The obtained residue was diluted with water and then washed with 
hexane. The aqueous layer was acidified with 1 M HCl to pH 2 and extracted with CHCl3. Combined 
organic extracts were washed with brine, dried over MgSO4, filtered, and concentrated under reduced 
pressure. To the residue was added CH3CN (1.5 mL), Cs2CO3 (170 mg, 0.522 mmol) and MeI (54.4 µL, 
0.873 mmol) at room temperature. After stirring for 11 h, the reaction mixture was diluted with CHCl3 
and filtered through a Celite pad. The filtrate was concentrated under reduced pressure, and the residue 
was purified by silica gel column chromatography (hexane/EtOAc = 9/1→6/4) to give 14 (87.9 mg, 70% 
over 3 steps) as a colorless oil: 1H NMR (400 MHz, CDCl3, δ); 7.44 (d, 1H, J = 7.6 Hz), 7.38 (dd, 1H, J1 
= J2 = 7.8 Hz), 7.12 (dd, 1H, J1 = 7.6 Hz, J2 = 7.5 Hz), 6.93 (d, 1H, J = 7.8 Hz), 3.53 (s, 3H), 3.28 (s, 3H), 
3.13–2.96 (m, 3H), 2.62 (d, 1H, J = 16.6 Hz); 13C NMR (100 MHz, CDCl3, δ); 176.4, 169.5, 143.9, 129.9, 
128.5, 123.4, 116.1, 109.0, 52.1, 46.1, 39.2, 26.8, 25.9; IR (CHCl3) 2341, 1715 cm–1; HRMS (M+H+) 
Calcd for C14H15N2O3: 259.1083. Found: 259.1082. 
4.4.3. Lactam 15: To a solution of 14 (18.1 mg, 70.2 µmol) and CoCl2•6H2O (33.3 mg, 140 µmol) in 
MeOH (3 mL) was added NaBH4 (20.8 mg, 550 µmol) in five portions over 2 h. After stirring for 15 min, 
10% w/v KOH in MeOH solution (1 mL) was added. After stirring for 3 h, 1 M HCl and brine were 
added, and the mixture was extracted with CHCl3. The combined extracts were washed with saturated 
aqueous NaHCO3 and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The 
residue was purified by silica gel column chromatography (CHCl3/MeOH = 97/3→95/5) to give 15 (7.8 
mg, 48%); mp 198.9–199.2 ºC; 1H NMR (400 MHz, CDCl3, δ); 7.34 (dd, 1H, J1 = 7.8 Hz, J2 = 7.5 Hz), 
7.27 (d, 1H, J = 7.1 Hz), 7.10 (dd, 1H, J1 = 7.5 Hz, J2 = 7.6 Hz), 6.91 (d, 1H, J = 7.6 Hz), 6.39 (br, 1H), 
3.75–3.69 (m, 1H), 3.64–3.57 (m, 1H), 3.25 (s, 3H), 2.82 (d, 1H, J = 17.6 Hz), 2.37 (d, 1H, J = 17.7 Hz), 
2.24–2.17 (m, 1H), 1.82–1.76 (m, 1H); 13CNMR (100 MHz, CDCl3, δ); 178.3, 170.3, 143.0, 131.7, 129.0, 
123.6, 123.2, 108.8, 46.1, 38.7, 37.7, 29.5, 26.6; IR (KBr) 3179, 1709, 1659 cm–1; HRMS (M+H+) Calcd 
for C13H15N2O2: 231.1134. Found: 231.1129. 
 
4.5 Synthesis of Pyrroloindole 17 
4.5.1. Carbamate 16: To a solution of (S)-2a (81% ee) (326 mg, 1.81 mmol) in MeOH (18 mL) was 
added CoCl2•6H2O (702 mg, 2.95 mmol) at 0 ºC, and the mixture was stirred for 15 min at the same 
temperature. NaBH4 (342 mg, 9.05 mmol) was added and stirring was continued at room temperature for 
2 h. After adding 2 M HCl at 0 ºC and neutralizing with saturated aqueous NaHCO3, the mixture was 
extracted with EtOAc. The combined organic extracts were washed with saturated aqueous potassium 
sodium tartrate, dried over Na2SO4, filtered, and concentrated under reduced pressure. To a solution of the 
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residue in pyridine (10 mL) was added 4-(N,N-dimethylamino)pyridine (12.5 mg, 0.102 mmol) and 
methylchloroformate (0.40 mL, 5.1 mmol) at 0 ºC. After stirring at room temperature overnight, saturated 
aqueous NH4Cl was added, and the mixture was extracted with EtOAc. The combined organic extracts 
were dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue obtained was 
purified by silica gel column chromatography (hexane/EtOAc = 9/1→7/3) to give carbamate 16 (182 mg, 
53% over 2 steps) as a colorless oil: 1H NMR (400 MHz, CDCl3, δ) 7.33–7.20 (m, 6H), 7.15 (ddd, 1H, J1 
= 1.2 Hz, J2 = J3 = 7.8 Hz), 7.04 (ddd, 1H, J1 = 1.2 Hz, J2 = J3 = 7.8 Hz), 6.74 (d, 1H, J = 7.8 Hz), 4.95 (d, 
1H, J = 15.8 Hz), 4.87 (d, 1H, J = 15.8 Hz), 4.85 (br, 1H), 3.58 (s, 3H), 3.02–2.91 (m, 2H), 2.21–2.14 (m, 
1H), 2.10–2.03 (m, 1H), 1.42 (s, 3H); 13C NMR (100 MHz, CDCl3, δ) 180.7, 157.0, 142.2, 136.1, 133.5, 
129.0, 128.2, 127.8, 127.4, 123.0, 122.9, 109.4, 52.0, 47.1, 43.8, 37.7, 37.5, 24.4; IR (CHCl3) 1708, 1611 
cm–1; MS (FAB) m/z = 339 (M+H+). 
4.5.2. Pyrroloindole 17: To solution of carbamate 16 (52.1 mg, 0.154 mmol) in THF was added LiAlH4 
(36.5 mg, 0.770 mmol) at 0 ºC. After stirring at room temperature for 1.5 h and at reflux for 10 min, 
Na2SO4•10H2O was added at 0 ºC. After stirring for 1 h at room temperature, the inorganic solid was 
removed by filtration. The filtrate was dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The residue obtained was purified by silica gel column chromatography (CHCl3/MeOH = 95/5) 
to give pyrroloindole 17 (18.3 mg, 43%) as a colorless oil. Spectra were identical to those reported 
previously[46]; [α]26D –68 (c = 0.20 in CH2Cl2). 
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